Eli Lilly spotlights early oncology in first pipeline review since R&D shift
Two weeks into the Josh Bilenker era at Eli Lilly, the legacy pharma was excited to spotlight three early-stage
Two weeks into the Josh Bilenker era at Eli Lilly, the legacy pharma was excited to spotlight three early-stage
Sanofi faces $250M charge after E. coli vaccine developed with J&J fails Phase 3 trial; study ends early due to insufficient efficacy in preventing invasive…
A federal court in Massachusetts temporarily blocked the Trump administration’s new cap on indirect cost reimbursements for NIH grant recipients within the 22 states that…
The FDA has approved Emblaveo in combination with metronidazole for complicated intra-abdominal infections, providing a new tool to fight antimicrobial resistance.
Every year Chris Dokomajilar at DealForma and Endpoints founding editor John Carroll collaborate on identifying the top 100 biotech VCs in operation, based on the…
Indian drugmaker Maithili Life Sciences has received a non-compliant report from the Brussels-based Federal Agency for Medicines and Health Products for issues related to APIs.
The Trump administration’s reported plans to potentially lay off thousands of FDA employees could slow the agency’s reviews of new drugs, experts say, in addition…
Private equity firm expects $3.3bn acquisition of Tanabe will get boost from eased approval process for new medicine
All nine late-stage kidney cancer patients in a Phase 1 trial of a personalized vaccine remained cancer-free after more than three years of receiving treatment,…
Robert F. Kennedy Jr. advances toward Senate confirmation despite vaccine controversy, as key skeptic Sen. Bill Cassidy backs nomination after receiving
Alzheimer’s disease has afflicted Hannah Richardson’s family for generations. A rare genetic mutation, passed down from her great-grandmother, has struck her relatives with the first…